Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A PIM-CHK1 signaling pathway regulates PLK1 phosphorylation and function during mitosis

View through CrossRef
ABSTRACT Although the kinase CHK1 is a key player in the DNA damage response (DDR), several studies have recently provided evidence of DDR-independent roles of CHK1, in particular following phosphorylation of its S280 residue. Here, we demonstrate that CHK1 S280 phosphorylation is cell cycle-dependent and peaks during mitosis. We found that this phosphorylation was catalyzed by the kinase PIM2, whose protein expression was also increased during mitosis. Importantly, we identified polo-like kinase 1 (PLK1) as a direct target of CHK1 during mitosis. Genetic or pharmacological inhibition of CHK1 reduced the activating phosphorylation of PLK1 on T210, and recombinant CHK1 was able to phosphorylate T210 of PLK1 in vitro. Accordingly, S280-phosphorylated CHK1 and PLK1 exhibited similar specific mitotic localizations, and PLK1 was co-immunoprecipitated with S280-phosphorylated CHK1 from mitotic cell extracts. Moreover, CHK1-mediated phosphorylation of PLK1 was dependent on S280 phosphorylation by PIM2. Inhibition of PIM proteins reduced cell proliferation and mitotic entry, which was rescued by expressing a T210D phosphomimetic mutant of PLK1. Altogether, these data identify a new PIM–CHK1–PLK1 phosphorylation cascade that regulates different mitotic steps independently of the CHK1 DDR function. This article has an associated First Person interview with the first author of the paper.
Title: A PIM-CHK1 signaling pathway regulates PLK1 phosphorylation and function during mitosis
Description:
ABSTRACT Although the kinase CHK1 is a key player in the DNA damage response (DDR), several studies have recently provided evidence of DDR-independent roles of CHK1, in particular following phosphorylation of its S280 residue.
Here, we demonstrate that CHK1 S280 phosphorylation is cell cycle-dependent and peaks during mitosis.
We found that this phosphorylation was catalyzed by the kinase PIM2, whose protein expression was also increased during mitosis.
Importantly, we identified polo-like kinase 1 (PLK1) as a direct target of CHK1 during mitosis.
Genetic or pharmacological inhibition of CHK1 reduced the activating phosphorylation of PLK1 on T210, and recombinant CHK1 was able to phosphorylate T210 of PLK1 in vitro.
Accordingly, S280-phosphorylated CHK1 and PLK1 exhibited similar specific mitotic localizations, and PLK1 was co-immunoprecipitated with S280-phosphorylated CHK1 from mitotic cell extracts.
Moreover, CHK1-mediated phosphorylation of PLK1 was dependent on S280 phosphorylation by PIM2.
Inhibition of PIM proteins reduced cell proliferation and mitotic entry, which was rescued by expressing a T210D phosphomimetic mutant of PLK1.
Altogether, these data identify a new PIM–CHK1–PLK1 phosphorylation cascade that regulates different mitotic steps independently of the CHK1 DDR function.
This article has an associated First Person interview with the first author of the paper.

Related Results

Abstract 1784: Enhancement of hypoxia-activated prodrug TH-302 activity by Chk1 inhibition
Abstract 1784: Enhancement of hypoxia-activated prodrug TH-302 activity by Chk1 inhibition
Abstract TH-302 is a hypoxia-activated prodrug currently in clinical trials for the treatment of cancer. TH-302 releases the DNA cross-linking bromo-isophosphoramide...
Abstract 1766: Investigating Chk1 biology with selective oral Chk1 inhibitor.
Abstract 1766: Investigating Chk1 biology with selective oral Chk1 inhibitor.
Abstract Chk1 inhibitor as a chemo-potentiator in cancer therapy was proposed more than 10 years ago. Most of the first generation i.v. dosing chk1 inhibitors were t...
Abstract 4758: Inhibition of checkpoint kinase 1 (Chk1) as a potential therapeutic for pediatric neuroblastoma
Abstract 4758: Inhibition of checkpoint kinase 1 (Chk1) as a potential therapeutic for pediatric neuroblastoma
Abstract Neuroblastoma is a cancer derived from cells of the sympathetic nervous system that manifests with significant clinical heterogeneity. Although children dia...
UBAP2L-dependent coupling of PLK1 localization and stability during mitosis
UBAP2L-dependent coupling of PLK1 localization and stability during mitosis
Abstract PLK1 is an important regulator of mitosis whose protein levels and activity fluctuate during the cell cycle. PLK1 dynamically localizes to various mitotic ...
Abstract 1133: Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state
Abstract 1133: Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state
Abstract One outcome of activation of the PI3K pathway is increased aerobic glycolysis, but the upstream signaling events that regulate the PI3K pathway, thus the Wa...

Back to Top